跳至主要内容
临床试验/NCT04627168
NCT04627168Unknown不适用

The Effects of Transcutaneous Abdominal Stimulation on Bowel Function in Persons With Spinal Cord Injury and in Able-bodied Persons With Chronic Constipation.

Amol Soin, M.D., MBA1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年10月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Total defecation time (duration)

研究概览

简要总结

This is a prospective, single-center, feasibility study to determine the sensations elicited by non-invasive abdominal electrical stimulation and its effects on bowel function in spinal cord injured individuals and in able-bodied persons with chronic constipation. Electrical stimulation will be delivered through commercially available equipment to each subject during a single site visit.

详细描述

This is a prospective, single-center, treatment feasibility study to determine the efficacy of electrical stimulation for bowel functions. The study will determine sensations elicited by non-invasive, transcutaneous abdominal electrical stimulation and its effects on bowel function in spinal cord injured individuals and in able-bodied persons with chronic constipation. The electrical stimulation will be delivered through commercially available equipment to each subject during a single site visit. Visits are anticipated to be no more than 5 hours.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •For spinal cord injury subject group:
  • •Traumatic or non-traumatic spinal cord injury;
  • •Constipation;
  • •Motor-complete or motor-incomplete spinal cord injury;
  • •Quadriplegia or paraplegia;
  • •Post-injury time ≥ 1 year;
  • •Neurogenic Bowel Dysfunction Score ≥
  • •For able-bodied subject group:
  • •Diagnosis of intestinal constipation according to the Rome IV criteria;
  • •Chronic constipation as defined by < 3 bowel movements per week for > 3 months.
  • •For both subject groups:
  • •Can read, understand and willingly sign an Institutional Review Board approved informed consent document that describes the study's risks and benefits.

排除标准

  • •Presence of any organic cause for intestinal constipation;
  • •Have chronic fecal incontinence;
  • •Have skin infection/lesion in the area of electrode application or systemic skin disease;
  • •Have an implanted electronic device (such as heart pacemaker, insulin or baclofen pump, etc);
  • •Have symptomatic cardiac disease;
  • •Have uncontrolled diabetes;
  • •Presence of abdominal hernia;
  • •Have a stoma, rectal tear, or untreated hemorrhoids;
  • •Have a significant psychiatric disorder;
  • •For female subjects, being pregnant, actively planning a pregnancy or breast-feeding a child;
  • •Be participating in another clinical study that would confound data analysis;
  • •Have a cognitive impairment or exhibits any characteristic that would limit the study candidate's ability to complete study assessments.

研究组 & 干预措施

Spinal cord injured persons

Experimental

Persons living with spinal cord injury presenting with constipation due to neurogenic bowel dysfunction.

干预措施: Non-invasive, surface electrical stimulation device, DS5 Digitimer (Device)

Persons without neurogenic bowel dysfunction

Experimental

Abled-bodied persons with chronic constipation.

干预措施: Non-invasive, surface electrical stimulation device, DS5 Digitimer (Device)

结局指标

主要结局

Total defecation time (duration)

时间窗: 7 days

The time (duration) to complete total defecation following the stimulation.

Duration of the occurrence of first stool

时间窗: 7 days

The time between the onset of transcutaneous abdominal electrical stimulation and the first stool will be measured.

次要结局

未报告次要终点

研究者

发起方
Amol Soin, M.D., MBA
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Amol Soin, M.D., MBA

Medical Director

Ohio Pain Clinic

研究点 (1)

Loading locations...

相似试验